Cheryl Lewis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Toxicology top 5%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 10
- DNA Repair Mechanisms 4
- Cancer-related gene regulation 4
- RNA modifications and cancer 4
-
- Cancer Immunotherapy and Biomarkers 6
-
- Immune Cell Function and Interaction 5
-
- BRCA gene mutations in cancer 4
- Co-authors
- David EuhusDawei BuSara MilchgrubJohn D. MinnaA. Marilyn LeitchWilliam S. WeintraubPaul KolmClaudine Jurkovitz
- Journals
- New England Journal of Medicine (1 paper)Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Cheryl Lewis
51 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 327
- Toxicology 65
- Cardiology and Cardiovascular Medicine 396
- Molecular Biology 826
- Radiology, Nuclear Medicine and Imaging 244
Countries citing papers authored by Cheryl Lewis
This map shows the geographic impact of Cheryl Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Lewis more than expected).
Fields of papers citing papers by Cheryl Lewis
This network shows the impact of papers produced by Cheryl Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Lewis. The network helps show where Cheryl Lewis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheryl Lewis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 30 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 41 | |
| 11 | 2020 | 20 | |
| 12 | 2015 | 34 | |
| 13 | 2013 | 11 | |
| 14 | 2013 | 84 | |
| 15 | 2011 | 126 | |
| 16 | 2011 | 13 | |
| 17 | 2008 | 40 | |
| 18 | 2006 | 27 | |
| 19 | 2006 | 10 | |
| 20 | 2003 | 39 |
About Cheryl Lewis
Cheryl Lewis is a scholar working on Cancer Research, Oncology and Aging, having authored 53 papers that have together received 1.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers), Immune Cell Function and Interaction (5 papers), DNA Repair Mechanisms (4 papers), BRCA gene mutations in cancer (4 papers), Cancer-related gene regulation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (327 citations), Toxicology (65 citations) and Cardiology and Cardiovascular Medicine (396 citations). Cheryl Lewis has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David Euhus, Dawei Bu, Sara Milchgrub, John D. Minna, A. Marilyn Leitch, William S. Weintraub, Paul Kolm, Claudine Jurkovitz, Leslie Cler and Robert A. O’Rourke. Their work appears in journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.